Ipsen S.A.
Pharmaceuticals
Company Summary
Ipsen S.A. is a biopharmaceutical firm with operations all over the world. Oncology, neuroscience, gastrointestinal, cognitive disorders, and uncommon diseases are among areas where the company delivers medications. Ipsen S.A. is based in Boulogne-Billancourt, France, and was founded in 1929.
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
30.2
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Refinitiv
Overall ESG Rating :
69
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
A
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Ipsen is average among 80 companies in the pharmaceuticals industry.
Temperature Rise :
1.4℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
